These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3327674)

  • 1. [Not Available].
    Müller T
    MMW Fortschr Med; 2024 May; 166(9):10. PubMed ID: 38755356
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension.
    Porcellati C; Verdecchia P; Gatteschi C; Benemio G; Guerrieri M; Boldrini F; Pollavini G
    Eur J Clin Pharmacol; 1989; 37(6):555-7. PubMed ID: 2612550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of quality of life on treatment with felodipine.
    Dimenäs E; Wallander MA; Svärdsudd K; Wiklund I
    Eur J Clin Pharmacol; 1991; 40(2):141-7. PubMed ID: 2065695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of renal ischaemic injury by felodipine.
    Thalén PG; Nordlander MI; Sohtell ME; Svensson LE
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):411-7. PubMed ID: 1852222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three methods of symptom reporting in a clinical trial of felodipine.
    Wallander MA; Dimenäs E; Svärdsudd K; Wiklund I
    Eur J Clin Pharmacol; 1991; 41(3):187-96. PubMed ID: 1748134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felodipine in combination with a beta-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension. The Australian Felodipine Multicentre Study Group.
    Frewin DB; Aldons P; Wilson LL; O'Sullivan EF; Wyndham RN; Karrasch J; Agar J; Singh BB; Jackson B; Atkins PF
    Eur J Clin Pharmacol; 1991; 41(5):393-6. PubMed ID: 1684748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse event monitoring in clinical trials of felodipine and omeprazole.
    Wallander MA; Lundborg P; Svärdsudd K
    Eur J Clin Pharmacol; 1992; 42(5):517-22. PubMed ID: 1606998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Felodipine in hypertension--a review.
    Elmfeldt D; Hedner T; Westerling S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S154-60. PubMed ID: 2442509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.
    Saltiel E; Ellrodt AG; Monk JP; Langley MS
    Drugs; 1988 Oct; 36(4):387-428. PubMed ID: 3069435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspects on the benefit-risk balance of felodipine in hypertension.
    Elmfeldt D; Westerling S
    Drugs; 1987; 34 Suppl 3():132-5. PubMed ID: 3327674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Felodipine monotherapy in hypertension.
    Littler WA; Smith SA; Mace PJ
    Drugs; 1987; 34 Suppl 3():107-8. PubMed ID: 3443057
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose tolerance and secretion and clearance of insulin during long term felodipine treatment.
    Katzman PL; Hulthén UL; Hökfelt B
    Drugs; 1987; 34 Suppl 3():93-4. PubMed ID: 3327685
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of long term felodipine treatment on renal vascular tone, glomerular filtration rate and renal tubular function in essential hypertension.
    Hulthén UL; Katzman PL; Hökfelt B
    Drugs; 1987; 34 Suppl 3():67-8. PubMed ID: 3443066
    [No Abstract]   [Full Text] [Related]  

  • 14. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.